Second Covid-19 vaccine approved for use in the UK

5 January 2021

The Oxford University/AstraZeneca Covid-19 vaccine has been approved for use in the UK by the MHRA, and the Joint Committee on Vaccination and Immunisation (JCVI) has issued updated advice recommending that as many people as possible in high-risk groups be given their first vaccine dose.

UK Covid alert level moves from level 4 to 5

5 January 2021

Prime Minister Boris Johnson announced on 4 January that the UK’s Covid-19 alert level will move from level 4 to 5 "meaning that if action is not taken, NHS capacity may be overwhelmed within 21 days".

NICE publishes rapid guideline on managing effects of long Covid

21 December 2020

A National Institute for Health and Care Excellence (NICE) final rapid guideline on identifying, assessing and managing the long-term effects of Covid-19 says GPs should consider long Covid referral after just 4 weeks and after ruling out other diagnoses.

Covid-19, work-related stress and mental health survey

15 December 2020

To help improve its understanding of the impact that the coronavirus is having on employers and workers, the Health and Safety Executive (HSE) is carrying out two surveys regarding the impact of Covid-19 on work-related stress and mental health.

Health Secretary calms fears over new coronavirus strain

15 December 2020

Addressing the House of Commons about plans to move London and parts of the South East into the strictest level of coronavirus rules (tier 3), Health Secretary Matt Hancock also reported that a new variant of coronavirus has been identified.